Aller au contenu principal
Profil bibliographique

Sadia Amin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées
178Citations signalées
0Affiliations récentes

Les domaines associés

Asthma and respiratory diseasesOral microbiology and periodontitis researchImmune Response and InflammationNetwork Security and Intrusion DetectionLipid Membrane Structure and Behavior

Les publications récentes

Accès ouvert 2021 article OpenAlex

Role of Interleukin- 34 together with Receptor Activator of Nuclear Factor kB ligand and Osteoprotegrin levels in Periodontal Disease

Noor Amin, Imrana Qureshi, Sana Naeem, SuhailMajid Jan et autres

Aim: To compare the levels and relative ratios of Interleukin-34, osteoprotegrin, and factor kB ligand in the crevicular fluid of individuals with periodontal disease. Study design & setting: Randomized Clinical Trial, Frontier Medical And Dental College, Abbotabad Methodology: We enrolled 15 healthy …

0 citations Pakistan Journal of Medical and Health Sciences
Accès ouvert 2017 article OpenAlex

Acute oral toxicity evaluation of aqueous ethanolic extract of Saccharum munja Roxb. roots in albino mice as per OECD 425 TG

Uzma Saleem, Sadia Amin, Bashir Ahmad, Haroon Azeem et autres

Background S. munja roots have been used in ethno medicines for the treatment of different ailments. Despite its beneficial uses no studies on its toxicity potential have been reported. Objective The study was designed to evaluate acute toxic potential of aqueous ethanolic …

pk (code pays fourni par la source)

154 citations Toxicology Reports
2013 article OpenAlex

Bioequivalence study of montelukast tablets in healthy Pakistani volunteers.

Mateen Abbas, Abdul Muqeet Khan, Sadia Amin, Sualeha Riffat et autres

Montelukast is a leukotrien receptor antagonist used for asthma treatment. Objective of this study was to evaluate the bioequivalence of two montelukast 10mg tablets, Innovator drug (Singulair) as reference and other locally manufactured drug (Montiget) in 12 healthy volunteers. It was randomized, …

pk (code pays fourni par la source)

4 citations PubMed
Accès ouvert 2012 article OpenAlex

Improvement of BGP Session Maintenance

Sadia Amin, Saira Ahthasham, Aftab Ahmed Shaikh, Ahthasham Sajid et autres

In the early days, the Internet used static routes, but very quickly network administrators couldnt keep manually updating their routing tables. Later, Internet network administrator used a protocol called EGP but EGP was not scalable so BGP was introduced to solve all …

pk (code pays fourni par la source)

0 citations International Journal of Engineering & Technology
2012 conference-paper OpenAlex

Bioequivalence Study of Deferiprone In Healthy Pakistani Volunteers

Muhammad Abbas, Abdul Muqeet Khan, Naila Waheed, Sualeha Riffat et autres

The study was conducted to evaluate the bioequivalence of deferiprone 500 mg with innovator drug in Pakistani men. Twenty four healthy volunteers were enrolled in this study. Each volunteer take two tablets of generic and innovator deferiprone with two-week washout period. Blood …

1 citation El Servicio de Difusión de la Creación Intelectual (National University of La Plata)
2008 article OpenAlex

Elastic Liposomes Bearing Meloxicam-β -Cyclodextrin for Transdermal Delivery

Sanjay Jain, Yashwant Gupta, Anekant Jain, Sadia Amin

The ultra-flexible lipid vesicles, the elastic liposomes bearing meloxicam-beta-cyclodextrin complex were prepared for its topical administration with the aim of simultaneously exploiting the favorable properties of both the carriers. The prepared meloxicam-beta-cyclodextrin complex was evaluated using DSC, XRD and FT-IR, which indicates …

in (code pays fourni par la source)

18 citations Current Drug Delivery

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.